Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review.
Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review.
复制标题
DOI:
10.4103/1319-3767.98436
复制
发表时间:
2012-07
期刊:
影响因子:
--
通讯作者:
Campos MJ
中科院分区:
文献类型:
--
作者:
Ferreira R;Carvalheiro J;Torres J;Fernandes A;Giestas S;Mendes S;Agostinho C;Campos MJ
Hepatitis B virus (HBV) reactivation is a well-recognized complication that occurs in lymphoma patients who undergo chemotherapy. Only very few cases of HBV reactivation in patients with isolated antibody against hepatitis B surface antigen (anti-HBs) have been reported. We present a case of a 78-year-old woman diagnosed with diffuse large B cell non-Hodgkin's lymphoma who only displayed a positive anti-HBs, as the single possible marker of occult HBV infection, before starting therapy. She was treated with several chemotherapeutic regimens (including rituximab) for disease relapses during 3 years. Forty days after the last cycle of chemotherapy, she presented with jaundice, markedly elevated serum aminotransferase levels, and coagulopathy. HBV serology showed positivity for HBsAg, anti-HBc and anti-HBs. HBV DNA was positive. Antiviral treatment with entecavir was promptly initiated, but the patient died from liver failure. A review of the literature of HBV reactivation in patients with detectable anti-HBs levels is discussed.
登录
查看更多内容
影响因子:
3.5
作者:
Pei, Sung-Nan;Chen, Chien-Hung;Kuo, Ching-Yuan
通讯作者:
Kuo, Ching-Yuan
影响因子:
4.6
作者:
Kim, Eui Bae;Kim, Dae Sik;Kim, Seok Jin
通讯作者:
Kim, Seok Jin
影响因子:
45.3
作者:
Yeo, Winnie;Chan, Tung C.;Chan, Paul K. S.
通讯作者:
Chan, Paul K. S.
影响因子:
50.5
作者:
Fukushima, N.;Mizuta, T.;Sueoka, E.
通讯作者:
Sueoka, E.
影响因子:
6.2
作者:
Matsue, Kosei;Kimura, Shun-ichi;Takeuchi, Masami
通讯作者:
Takeuchi, Masami